Tecomet and Orchid Orthopedic Solutions have successful closed their merger, forming a scaled global manufacturing partner serving medtech, aerospace and defense customers. The combined company will operate under the Tecomet name.
Tecomet will offer expanded capabilities across precision machining, additive manufacturing, forging, casting, and advanced finishing, supported by a more integrated global manufacturing platform. This combination positions Tecomet to support customers across the product lifecycle from product development through full-scale production with greater speed, flexibility, and supply assurance.
Andreas Weller, CEO of Tecomet, has been named CEO of the combined company.
“This combination is about more than scale. It is about building a platform that can meet the increasing complexity and demands of our customers with greater precision, reliability, and speed,” said Weller in a statement. “We are bringing together capabilities that are highly complementary to create a more complete and resilient manufacturing partner.”
As integration begins, the company said it will focus on operational continuity across all sites. Core priorities including safety, quality, regulatory compliance, and on-time delivery remain unchanged, while dedicated Integration teams coordinate closely to minimize disruption and ensure a seamless transition for customers. Integration will be phased to align capabilities and operations while minimizing disruption. The combined organization is well-positioned to invest in advanced manufacturing, automation, and operational excellence, further strengthening its ability to support long-term customer growth and innovation.
